Responses
Spondyloarthritis
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Compose a Response to This Article
Other responses
No responses have been published for this article.